Showing results (71-80 of 112) with videos related to

Sort By:
Pageof 12
Biomacromolecules|December 2, 2021
Intrinsically Fluorescent Oligomeric Cytotoxic Conjugates Toxic for FGFR1-Overproducing CancersNatalia Porębska, Agata Knapik, Marta Poźniak, et al.
Molecular Pharmaceutics|April 7, 2022
Drug Conjugation via Maleimide-Thiol Chemistry Does Not Affect Targeting Properties of Cysteine-Containing Anti-FGFR1 PeptibodiesKarolina Jendryczko, Jakub Rzeszotko, Mateusz Adam Krzyscik, et al.
Cells|February 15, 2022
Nuclear Localization Sequence of FGF1 Is Not Required for Its Intracellular Anti-Apoptotic Activity in Differentiated CellsAgata Lampart, Katarzyna Dominika Sluzalska, Aleksandra Czyrek, et al.
Acta Crystallographica. Section D, Biological Crystallography|November 28, 2002
The impact of Glu-->Ala and Glu-->Asp mutations on the crystallization properties of RhoGDI: the structure of RhoGDI at 1.3 A resolutionAgnieszka Mateja, Yancho Devedjiev, Daniel Krowarsch, et al.
Acta Crystallographica. Section D, Biological Crystallography|March 25, 2004
Preliminary crystallographic analysis of the complex of the human GTPase RhoA with the DH/PH tandem of PDZ-RhoGEFArkadiusz Oleksy, Holly Barton, Yancho Devedjiev, et al.
Acta Crystallographica. Section D, Biological Crystallography|January 21, 2009
Structure of a highly stable mutant of human fibroblast growth factor 1Anna Szlachcic, Małgorzata Zakrzewska, Daniel Krowarsch, et al.
International Journal of Molecular Sciences|August 24, 2018
Specific Antibody Fragment Ligand Traps Blocking FGF1 ActivityJulia Chudzian, Anna Szlachcic, Malgorzata Zakrzewska, et al.
Cancers|October 20, 2020
FGF2-Derived PeptibodyF2-MMAE Conjugate for Targeted Delivery of Cytotoxic Drugs into Cancer Cells Overexpressing FGFR1Karolina Jendryczko, Julia Chudzian, Natalia Skinder, et al.
Journal of Molecular Biology|August 13, 2018
Translocation of Exogenous FGF1 and FGF2 Protects the Cell against Apoptosis Independently of Receptor ActivationMichal Kostas, Agata Lampart, Joanna Bober, et al.
International Journal of Molecular Sciences|February 21, 2017
A Conjugate Based on Anti-HER2 Diaffibody and Auristatin E Targets HER2-Positive Cancer CellsAnna M Serwotka-Suszczak, Alicja M Sochaj-Gregorczyk, Jerzy Pieczykolan, et al.
Pageof 12